Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ (“Nightingale Health”) to act as depositary bank for its sponsored Level 1 American Depositary Receipt (“ADR”) program.
Nightingale Health’s ADRs are traded on the OTCQX platform under the symbol “NHLTY”. Each ADR represents one ordinary share of the company. Nightingale Health’s underlying ordinary shares are listed and traded on the Nasdaq Helsinki Stock Exchange under the symbol “HEALTH FH”.
“We are excited to work with Citi on our ADR program which enables U.S. investors to easily trade our shares,” said Teemu Suna, Nightingale Health’s CEO and Founder. “Our ambitions are highly global, and the U.S represents the world’s largest healthcare market. We continue to expand our business in the market and providing U.S. investors with greater access to our firm aligns perfectly with our global growth strategy.”
Dirk Jones, Head of Issuer Services at Citi said: “By leveraging Citi’s global network, we have the ability to support issuers to expand and diversify their shareholder base by accessing global capital markets. Through our Issuer Services business, Citi offers a high-quality ADR service which will facilitate the success of Nightingale Health’s Level 1 ADR program.”
Citi Issuer Services is a leading provider of depositary receipt services. With depositary receipt programs in over 65 markets, spanning equity and fixed-income products, Issuer Services leverages Citi’s global network to provide cross-border capital market access to issuers, intermediaries, and investors.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
